In the present study, 3 patients with RBC lifespans of more than 30 days carried SPTB or SLC4A1 mutations, and patients with ANK1 or SPTA1 mutations showed a trend towards more severe hemolysis.
1
—
—
In the present study, 3 patients with RBC lifespans of more than 30 days carried SPTB or SLC4A1 mutations, and patients with ANK1 or SPTA1 mutations showed a trend towards more severe hemolysis.